David Hallas Purchases 15,500 Shares of ECO Animal Health Group plc (LON:EAH) Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas acquired 15,500 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was acquired at an average price of GBX 74 ($0.94) per share, for a total transaction of £11,470 ($14,533.71).

ECO Animal Health Group Price Performance

EAH stock opened at GBX 73 ($0.92) on Wednesday. The firm has a 50-day moving average of GBX 73.27 and a 200 day moving average of GBX 101.46. The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The company has a market cap of £49.45 million, a P/E ratio of 3,650.00 and a beta of -0.05. ECO Animal Health Group plc has a 1 year low of GBX 60 ($0.76) and a 1 year high of GBX 135 ($1.71).

Analyst Upgrades and Downgrades

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a report on Friday, November 29th.

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.